State-of-the-art remote-participation research seeks to understand how genetic factors linked to intense activities and lipid metabolism may increase ALS susceptibility...
07.22.2025
NEW ORLEANS, July 22, 2025 — Answer ALS is proud to announce the launch of a groundbreaking collaborative initiative aimed...
05.16.2025
Terri Thompson’s Multidisciplinary Approach Terri Thompson didn’t set out to work in ALS research. She had been working on a...
03.15.2025
Answer ALS is deeply alarmed and disappointed by Congress’ passage of the Full-Year Continuing Appropriations Act, which includes devastating cuts...
12.05.2024
Integrated data sharing platforms to accelerate research into ALS and Alzheimer’s disease by providing access to collaborative tools and datasets
11.14.2024
Unprecedented resource, created with Cedars-Sinai, to accelerate ALS research and drive development of targeted therapies globally
03.07.2024
The ALS Therapy Development Institute (ALS TDI), Answer ALS, and Microsoft are pleased to announce a collaboration that will bring...
01.30.2024
Dr. Jeffrey Keller to Co-Lead Answer ALS’ Unprecedented Open Access ALS Data Repository. Appointment to Answer ALS bridges revolutionary data...
12.19.2023
10 Years of Commitments Met. Ten years ago, Answer ALS didn’t have a name, but the plan was developed to...
03.02.2023
Our 2022 4th quarter newsletter is available here. There has been a lot to celebrate, but there is so much...
03.02.2023
ALS Motor Neurons Differ by Sex, Study Finds. A new Cedars-Sinai study in collaboration with the University of California, Irvine...
01.23.2022
Answer ALS is excited to announce Danielle Boyce, DPA, MPH as the new Executive Director for Answer ALS Research, coupled...
